Mifepristone in Refractory Depression
Completed · Not applicable · Has a placebo group
Conditions studied: Depression
In brief
The purpose of the study is to examine the effectiveness of mifepristone treatment in patients with refractory depression. Refractory depression is defined as clinical depression that is unimproved after treatment with at least 2 different antidepressants of adequate dose and time trial. Mifepristone will augment current medications.
Key facts
- Study ID
- NCT00186056
- Run by
- Stanford University
- People needed
- 31
- Starts
- 2003-01-01
- Expected to finish
- 2007-05-01
- Last updated by the study team
- 2017-04-05
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.